Printer Friendly
The Free Library
14,634,648 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AVI BioPharma Announces Second Quarter 1998 Financial Results.


PORTLAND, Ore.--(BW HEALTHWIRE)--Aug. 4, 1998--AVI BIOPHARMA ("AVI (Audio Video Interleaved) A Windows multimedia video format from Microsoft. It interleaves standard waveform audio and digital video frames (bitmaps) to provide reduced animation at 15 fps at 160x120x8 resolution. Audio is 11,025Hz, 8-bit samples. ")(Nasdaq: AVII, AVIIW), formerly known as AntiVirals Inc., today reported financial results for the six months ended June 30, 1998. For the seresearch contract revenue in the second quarter 1998 of $6,153 compared with $3,754 in the second quarter of1,858,091 or $0.20 per share for the same periodexpenses increased to $2,598,439 compared with or the six months ended June 30, 1998 from $1,95ical testing of AVI's technologies.

Denis Denis, king of Portugal: see Diniz.  Burger, Ph.D., President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of AVI BioPharma, stated, "Tne(TM) cancer vaccine in pancreatic cancer pancreatic cancer

Malignant tumour of the pancreas. Risk factors include smoking, a diet high in fat, exposure to certain industrial products, and diseases such as diabetes and chronic pancreatitis. Pancreatic cancer is more common in men.
 and d early 1999.

"From a financial perspective, the second quarter results are in-line with our expectations. We will incur additional future expenses as our developmenitical juncture, we are diligently seeking to establish a pharmaceutical collaborative arrangement, which wito the development and commercialization of proe treatment of a wide range of human diseases including cancer and restenosis, a cardiovascular disease. The DA-approved drugs, drugs in development, and an of Directors of both companies and is pending are forward-looking statements that involve risks and uncertainties including, but not limited to, the results of research and development efforts, the results of pre-cl other agencies, the impact of competitive prod June 30,

1998 1997 1998 1997

11,803 $3,754

Operating expenses: Research and

development 1,304,174 921,9 -------- ------- -------- ---======= ======= = ====== =======

Shares used in per share calculations 11,166,536 9,387,998 11,157,240 9,085,566

==========ANCE ANCE Associazione Nazionale Costruttori
ANCE Association of Network for Community Empowerment (Lahore, Pakistan)
ANCE Agence Nationale de Certification Électronique (French) 
 SHEET HIGHLIGHTS

sets 14,451,665 17,657,978,317,762


CONTAations Contact:

CPR Cardiopulmonary Resuscitation (CPR) Definition

Cardiopulmonary resuscitation (CPR) is a procedure to support and maintain breathing and circulation for a person who has stopped breathing (respiratory arrest) and/or whose heart has stopped (cardiac
 Financial Communications, LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control


Olga M. Fleming/Sue L. Yeoh
COPYRIGHT 1998 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 4, 1998
Words:271
Previous Article:GlobeSet Announces Availability of SET Marked GlobeSet POS v1.2 Software; Product Available Through OEM Channel Partners.
Next Article:Hecla Reports Successful Second Quarter For the Period Ended June 30, 1998.
Topics:



Related Articles
AVI BioPharma Initiates GMP Manufacturing Contracts for its Morpholine Antisense Compounds.
AVI BIOPHARMA And ImmunoTherapy Corporation Announce the Initiation of a Late-Stage Clinical Trial for Their Therapeutic Cancer Vaccine.
AVI BioPharma Announces Second Quarter Results.
AVI BioPharma Announces Second Quarter Financial Results.
AVI BioPharma Announces Second Quarter Financial Results Conference Call.
AVI BioPharma Announces Second Quarter Financial Results; Company Advances Clinical Development Programs, Strengthens Cash Position.
AVI BioPharma Announces Third Quarter Financial Results Conference Call.
AVI BioPharma Announces 2003 Fourth Quarter and Year-End Financial Results Conference Call.
AVI BioPharma Announces 2004 First Quarter Financial Results Conference Call.
AVI BioPharma Reports Second Quarter Financial Results; Conference Call Begins Today at 11:00 a.m. Eastern Time.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles